DR. MARVIN H SLEISENGER, MD
Osteopathic Medicine at Clement St, San Francisco, CA
License number
California GFE16244
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
2
4150 Clement St, San Francisco, CA 94121
415 Crown Rd, San Rafael, CA 94904
415 Crown Rd, San Rafael, CA 94904
Phone
(415) 750-6923
Personal information
See more information about MARVIN H SLEISENGER at radaris.comName
Address
Phone
415 Crown Rd, Greenbrae, CA 94904
415 Crown Rd, Greenbrae, CA 94904
Crown Rd, Kentfield, CA 94904
Palm Desert, CA
Professional information
Marvin Herbert Sleisenger, San Francisco CA
Specialties:
Internal Medicine, Gastroenterology
Work:
San Francisco Veterans Affairs Medical Center
4150 Clement St, San Francisco, CA 94121
4150 Clement St, San Francisco, CA 94121
Education:
Harvard University(1947)
Dr. Marvin H Sleisenger, San Francisco CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
4150 Clement St, San Francisco 94121
(415) 750-6923 (Phone), (415) 750-2185 (Fax)
(415) 750-6923 (Phone), (415) 750-2185 (Fax)
Certifications:
Internal Medicine, 1954
Awards:
Healthgrades Honor Roll
Languages:
English, German
Hospitals:
4150 Clement St, San Francisco 94121
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
Education:
Medical School
Harvard Medical School
Graduated: 1947
Beth Israel Deaconess Medical Center
Hospital Of The University Of Pennsylvania
Ny-Cornell
Harvard Medical School
Graduated: 1947
Beth Israel Deaconess Medical Center
Hospital Of The University Of Pennsylvania
Ny-Cornell
Use Of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives As Colon Cancer Chemopreventative And Chemotherapeutic Agents
US Patent:
5905073, May 18, 1999
Filed:
Jul 11, 1996
Appl. No.:
8/669377
Inventors:
Lorin K. Johnson - Pleasanton CA
Marvin H. Sleisenger - Kentfield CA
Marvin H. Sleisenger - Kentfield CA
Assignee:
Salix Pharmaceuticals, Inc. - Palo Alto CA
International Classification:
A61K31/63;31/615
US Classification:
514150
Abstract:
The present invention provides a method of colon cancer chemoprevention or chemotherapy comprising administering to an individual suffering from colon cancer or at risk to develop colon cancer a pharmaceutical composition comprising an effective amount of a 2-hydroxy-5-phenylazobenzoic acid derivative or an ester of an active metabolite or an oxidation product of an active metabolite thereof, or a pharmacologically acceptable salt of the 2-hydroxy-5-phenylazobenzoic acid derivative or an ester or an active metabolite or an oxidation product of an active matabolite thereof.
Use Of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives As Colon Cancer Chemopreventative And Chemotherapeutic Agents
US Patent:
5498608, Mar 12, 1996
Filed:
Jan 7, 1994
Appl. No.:
8/178578
Inventors:
Lorin K. Johnson - Pleasanton CA
Marvin H. Sleisenger - Kentfield CA
Marvin H. Sleisenger - Kentfield CA
Assignee:
Salix Pharmaceuticals - Palo Alto CA
International Classification:
A61K 31655, A61K 31615
US Classification:
514150
Abstract:
The present invention provides a method of colon cancer chemoprevention or chemotherapy comprising administering to an individual suffering from colon cancer or at risk to develop colon cancer a pharmaceutical composition comprising an effective amount of a 2-hydroxy-5-phenylazobenzoic acid derivative or an ester of an active metabolite thereof, or a pharmacologically acceptable salt of the 2-hydroxy-5-phenylazobenzoic acid derivative or an ester or an active metabolite thereof.